Edwards Lifesciences’s board of directors approved a two-for-one split of the company’s common shares of stock on Nov. 19, its first stock split since May 2010.
Stockholders who own shares as of close of business on Nov. 30 will receive an additional share of common stock for each share owned, according to an Edwards news release. The shares will be issued on Dec. 11.
Edwards expects the number of common shares to increase from approximately 108 million to approximately 216 million.
In October, Edwards announced its worldwide sales increased 1.3 percent in the third quarter compared with the previous period in 2014. The company's transcatheter heart valve therapy business saw a revenue increase of 10.8 percent.